Multicenter validation study of a prognostic index for portal vein tumor thrombosis in hepatocellular carcinoma

Jeong Il Yu, Sang Min Yoon, Hee Chul Park, Jong Hoon Kim, Tae Hyun Kim, Joong Won Park, Jinsil Seong, Ik Jae Lee, Hong Seok Jang, Chul Seung Kay, Chul Yong Kim, Eui Kyu Chie, Jin Hee Kim, Mi Sook Kim, Young Min Choi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Purpose: We previously reported on a staging system and prognostic index (PITH) for portal vein tumor thrombosis (PVTT) in hepatocellular carcinoma (HCC) patients treated with radiotherapy (RT) at a single institution. The aim of this study is to validate the PITH staging system using data from patients at other institutions and to compare it with other published staging systems. Materials and Methods: A total of 994 HCC patients with PVTT who were treated with RT between 1998 and 2011 by the Korean Radiation Oncology Group were analyzed retrospectively. All patients were staged using the Cancer of the Liver Italian Program (CLIP), Japanese Integrated Staging (JIS), Okuda, and PITH staging systems, and survival data were analyzed. The likelihood ratio, Akaike information criteria (AIC), time-dependent receiver operating characteristics, and prediction error curve analysis were used to determine discriminatory ability for comparison of staging systems. Results: The median survival was 9.2 months. Compared with the other staging systems, the PITH score gave the highest values for likelihood ratio and lowest AIC values, demonstrating that PITH may be a better prognostic model. Although the values were not significant and differences were not exceptional, the PITH score showed slightly better performance with respect to time-dependent area under curve and integrated Brier score of prediction error curve. Conclusion: The PITH staging system was validated in this multicenter retrospective study and showed better stratification ability in HCC patients with PVTT than other systems.

Original languageEnglish
Pages (from-to)348-357
Number of pages10
JournalCancer Research and Treatment
Volume46
Issue number4
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Validation Studies
Portal Vein
Multicenter Studies
Hepatocellular Carcinoma
Thrombosis
Neoplasms
Information Systems
Radiotherapy
Radiation Oncology
Survival
Liver Neoplasms
ROC Curve
Area Under Curve
Retrospective Studies

Keywords

  • Hepatocellular carcinoma
  • Multicenter study
  • Portal vein
  • Radiotherapy
  • Validation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Yu, J. I., Yoon, S. M., Park, H. C., Kim, J. H., Kim, T. H., Park, J. W., ... Choi, Y. M. (2014). Multicenter validation study of a prognostic index for portal vein tumor thrombosis in hepatocellular carcinoma. Cancer Research and Treatment, 46(4), 348-357. https://doi.org/10.4143/crt.2013.142

Multicenter validation study of a prognostic index for portal vein tumor thrombosis in hepatocellular carcinoma. / Yu, Jeong Il; Yoon, Sang Min; Park, Hee Chul; Kim, Jong Hoon; Kim, Tae Hyun; Park, Joong Won; Seong, Jinsil; Lee, Ik Jae; Jang, Hong Seok; Kay, Chul Seung; Kim, Chul Yong; Chie, Eui Kyu; Kim, Jin Hee; Kim, Mi Sook; Choi, Young Min.

In: Cancer Research and Treatment, Vol. 46, No. 4, 01.01.2014, p. 348-357.

Research output: Contribution to journalArticle

Yu, JI, Yoon, SM, Park, HC, Kim, JH, Kim, TH, Park, JW, Seong, J, Lee, IJ, Jang, HS, Kay, CS, Kim, CY, Chie, EK, Kim, JH, Kim, MS & Choi, YM 2014, 'Multicenter validation study of a prognostic index for portal vein tumor thrombosis in hepatocellular carcinoma', Cancer Research and Treatment, vol. 46, no. 4, pp. 348-357. https://doi.org/10.4143/crt.2013.142
Yu, Jeong Il ; Yoon, Sang Min ; Park, Hee Chul ; Kim, Jong Hoon ; Kim, Tae Hyun ; Park, Joong Won ; Seong, Jinsil ; Lee, Ik Jae ; Jang, Hong Seok ; Kay, Chul Seung ; Kim, Chul Yong ; Chie, Eui Kyu ; Kim, Jin Hee ; Kim, Mi Sook ; Choi, Young Min. / Multicenter validation study of a prognostic index for portal vein tumor thrombosis in hepatocellular carcinoma. In: Cancer Research and Treatment. 2014 ; Vol. 46, No. 4. pp. 348-357.
@article{c98f5b4f9cc84e639dbd59c11f04e29f,
title = "Multicenter validation study of a prognostic index for portal vein tumor thrombosis in hepatocellular carcinoma",
abstract = "Purpose: We previously reported on a staging system and prognostic index (PITH) for portal vein tumor thrombosis (PVTT) in hepatocellular carcinoma (HCC) patients treated with radiotherapy (RT) at a single institution. The aim of this study is to validate the PITH staging system using data from patients at other institutions and to compare it with other published staging systems. Materials and Methods: A total of 994 HCC patients with PVTT who were treated with RT between 1998 and 2011 by the Korean Radiation Oncology Group were analyzed retrospectively. All patients were staged using the Cancer of the Liver Italian Program (CLIP), Japanese Integrated Staging (JIS), Okuda, and PITH staging systems, and survival data were analyzed. The likelihood ratio, Akaike information criteria (AIC), time-dependent receiver operating characteristics, and prediction error curve analysis were used to determine discriminatory ability for comparison of staging systems. Results: The median survival was 9.2 months. Compared with the other staging systems, the PITH score gave the highest values for likelihood ratio and lowest AIC values, demonstrating that PITH may be a better prognostic model. Although the values were not significant and differences were not exceptional, the PITH score showed slightly better performance with respect to time-dependent area under curve and integrated Brier score of prediction error curve. Conclusion: The PITH staging system was validated in this multicenter retrospective study and showed better stratification ability in HCC patients with PVTT than other systems.",
keywords = "Hepatocellular carcinoma, Multicenter study, Portal vein, Radiotherapy, Validation",
author = "Yu, {Jeong Il} and Yoon, {Sang Min} and Park, {Hee Chul} and Kim, {Jong Hoon} and Kim, {Tae Hyun} and Park, {Joong Won} and Jinsil Seong and Lee, {Ik Jae} and Jang, {Hong Seok} and Kay, {Chul Seung} and Kim, {Chul Yong} and Chie, {Eui Kyu} and Kim, {Jin Hee} and Kim, {Mi Sook} and Choi, {Young Min}",
year = "2014",
month = "1",
day = "1",
doi = "10.4143/crt.2013.142",
language = "English",
volume = "46",
pages = "348--357",
journal = "Cancer Research and Treatment",
issn = "1598-2998",
publisher = "Korean Society for Thoracic and Cardiovascular Surgery",
number = "4",

}

TY - JOUR

T1 - Multicenter validation study of a prognostic index for portal vein tumor thrombosis in hepatocellular carcinoma

AU - Yu, Jeong Il

AU - Yoon, Sang Min

AU - Park, Hee Chul

AU - Kim, Jong Hoon

AU - Kim, Tae Hyun

AU - Park, Joong Won

AU - Seong, Jinsil

AU - Lee, Ik Jae

AU - Jang, Hong Seok

AU - Kay, Chul Seung

AU - Kim, Chul Yong

AU - Chie, Eui Kyu

AU - Kim, Jin Hee

AU - Kim, Mi Sook

AU - Choi, Young Min

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Purpose: We previously reported on a staging system and prognostic index (PITH) for portal vein tumor thrombosis (PVTT) in hepatocellular carcinoma (HCC) patients treated with radiotherapy (RT) at a single institution. The aim of this study is to validate the PITH staging system using data from patients at other institutions and to compare it with other published staging systems. Materials and Methods: A total of 994 HCC patients with PVTT who were treated with RT between 1998 and 2011 by the Korean Radiation Oncology Group were analyzed retrospectively. All patients were staged using the Cancer of the Liver Italian Program (CLIP), Japanese Integrated Staging (JIS), Okuda, and PITH staging systems, and survival data were analyzed. The likelihood ratio, Akaike information criteria (AIC), time-dependent receiver operating characteristics, and prediction error curve analysis were used to determine discriminatory ability for comparison of staging systems. Results: The median survival was 9.2 months. Compared with the other staging systems, the PITH score gave the highest values for likelihood ratio and lowest AIC values, demonstrating that PITH may be a better prognostic model. Although the values were not significant and differences were not exceptional, the PITH score showed slightly better performance with respect to time-dependent area under curve and integrated Brier score of prediction error curve. Conclusion: The PITH staging system was validated in this multicenter retrospective study and showed better stratification ability in HCC patients with PVTT than other systems.

AB - Purpose: We previously reported on a staging system and prognostic index (PITH) for portal vein tumor thrombosis (PVTT) in hepatocellular carcinoma (HCC) patients treated with radiotherapy (RT) at a single institution. The aim of this study is to validate the PITH staging system using data from patients at other institutions and to compare it with other published staging systems. Materials and Methods: A total of 994 HCC patients with PVTT who were treated with RT between 1998 and 2011 by the Korean Radiation Oncology Group were analyzed retrospectively. All patients were staged using the Cancer of the Liver Italian Program (CLIP), Japanese Integrated Staging (JIS), Okuda, and PITH staging systems, and survival data were analyzed. The likelihood ratio, Akaike information criteria (AIC), time-dependent receiver operating characteristics, and prediction error curve analysis were used to determine discriminatory ability for comparison of staging systems. Results: The median survival was 9.2 months. Compared with the other staging systems, the PITH score gave the highest values for likelihood ratio and lowest AIC values, demonstrating that PITH may be a better prognostic model. Although the values were not significant and differences were not exceptional, the PITH score showed slightly better performance with respect to time-dependent area under curve and integrated Brier score of prediction error curve. Conclusion: The PITH staging system was validated in this multicenter retrospective study and showed better stratification ability in HCC patients with PVTT than other systems.

KW - Hepatocellular carcinoma

KW - Multicenter study

KW - Portal vein

KW - Radiotherapy

KW - Validation

UR - http://www.scopus.com/inward/record.url?scp=84907922760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907922760&partnerID=8YFLogxK

U2 - 10.4143/crt.2013.142

DO - 10.4143/crt.2013.142

M3 - Article

VL - 46

SP - 348

EP - 357

JO - Cancer Research and Treatment

JF - Cancer Research and Treatment

SN - 1598-2998

IS - 4

ER -